Harrington-Smith Kristen 4
4 · eFFECTOR Therapeutics, Inc. · Filed Feb 17, 2022
Insider Transaction Report
Form 4
Harrington-Smith Kristen
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-02-15+40,000→ 40,000 totalExercise: $4.61Exp: 2032-02-14→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest in substantially equal monthly installments over three years, commencing on February 15, 2022, subject to the Reporting Person's continued service with the Issuer through each vesting date.